Novel antithrombotic agents to prevent hemodialysis vascular access failure
Ended Project Grant Awarded Last action
- Award ID
- R44HL093848
- Recipient
-
Evas Therapeutics LLC UEI N7UMM55RJ7S5
- Awarding agency
-
National Institutes of Health
Department of Health and Human Services
- Obligated
- $1,365,616
Award facts
- Assistance listing
- 93.839 Blood Diseases and Resources Research
- Completion date
- Originally
- Place of performance
- Manchester, MO 63021, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $638,409 | |
| Original award | $727,207 |
Quick answers
Who received award R44HL093848?
R44HL093848 was awarded to Evas Therapeutics LLC by National Institutes of Health (Department of Health and Human Services) on July 1, 2008.
How much is award R44HL093848 worth?
$1,365,616 has been obligated on R44HL093848.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award